Marmara Pharmaceutical Journal 2018 , Vol 22 , Issue 2
Synthesis and antiviral activity evaluation of new 4-thiazolidinones bearing an imidazo[2,1-b]thiazole moiety
Nuray Ulusoy Güzeldemirci1,Erkan Pehlivan1,Lieve Naesens2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, İstanbul University, Beyazıt 34116 İstanbul, Turkey
2Rega Institute for Medical Research, KU Leuven, B-3000 Leuven, Belgium
DOI : 10.12991/mpj.2018.61 A series of new 4-thiazolidinone derivatives were synthesized and evaluated against diverse DNA- and RNA-viruses in mammalian cell cultures. Some of the compounds were found to exhibit moderate antiviral activity. 3-Propyl-2-[((6-(4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl)acetyl)hydrazono]-5-methyl-4-thiazolidinone 13, displayed modest yet consistent activity against three strains of influenza A virus, including the 2009 pandemic virus A/H1N1 Virginia/ATCC3/2009 (cytotoxicity >100 μM). Compounds 6 and 11 displayed activity against vesicular stomatitis virus in HeLa cells (antiviral EC50 values of 9 (cytotoxicity 100 μM) and 2 μM (cytotoxicity 20 μM), respectively). Neither of the compounds was active against HIV. Keywords : Imidazo[2,1-b]thiazoles, 4-thiazolidinones, antiviral activity, synthesis